Raymond James announces AbbVie (NYSE:ABBV) Price Target of $177

By / / Abbvie, Raymond James

Raymond James analyst Gary Nachman initiates coverage on AbbVie (NYSE:ABBV) with a Outperform rating and announces Price Target of $177.

Scroll to Top